10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

APDN (Applied DNA Sciences Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Applied DNA Sciences Inc together

I guess you are interested in Applied DNA Sciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Applied DNA Sciences Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Applied DNA Sciences Inc’s Price Targets

I'm going to help you getting a better view of Applied DNA Sciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Applied DNA Sciences Inc

I send you an email if I find something interesting about Applied DNA Sciences Inc.

1. Quick Overview

1.1. Quick analysis of Applied DNA Sciences Inc (30 sec.)










1.2. What can you expect buying and holding a share of Applied DNA Sciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$21.90
When do you have the money?
1 year
How often do you get paid?
17.5%

What is your share worth?

Current worth
$5.77
Expected worth in 1 year
$11.73
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
$27.87
Return On Investment
521.8%

For what price can you sell your share?

Current Price per Share
$5.34
Expected price per share
$4.38 - $13.95
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Applied DNA Sciences Inc (5 min.)




Live pricePrice per Share (EOD)
$5.34
Intrinsic Value Per Share
$-177.91 - $-49.91
Total Value Per Share
$-172.15 - $-44.15

2.2. Growth of Applied DNA Sciences Inc (5 min.)




Is Applied DNA Sciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$10.2m$4m$6.9m63.6%

How much money is Applied DNA Sciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$7.8m-$3m-$4.7m-60.5%
Net Profit Margin-789.7%-295.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Applied DNA Sciences Inc (5 min.)




2.4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#94 / 127

Most Revenue
#112 / 127

Most Profit
#86 / 127

Most Efficient
#118 / 127
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Applied DNA Sciences Inc?

Welcome investor! Applied DNA Sciences Inc's management wants to use your money to grow the business. In return you get a share of Applied DNA Sciences Inc.

First you should know what it really means to hold a share of Applied DNA Sciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Applied DNA Sciences Inc is $5.34. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Applied DNA Sciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Applied DNA Sciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $5.77. Based on the TTM, the Book Value Change Per Share is $1.49 per quarter. Based on the YOY, the Book Value Change Per Share is $-3.91 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $5.47 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Applied DNA Sciences Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-15.35-287.5%-3.79-71.0%-3.83-71.7%-3.71-69.5%-4.95-92.8%-5.05-94.6%
Usd Book Value Change Per Share5.37100.5%1.4927.9%-3.91-73.2%-0.75-14.0%-0.41-7.7%0.050.9%
Usd Dividend Per Share21.90410.1%5.47102.5%0.000.0%1.8434.5%1.1220.9%0.5610.5%
Usd Total Gains Per Share27.27510.6%6.97130.5%-3.91-73.2%1.1020.5%0.7013.2%0.6111.4%
Usd Price Per Share1.66-0.73-0.88-0.93-2.88-2.57-
Price to Earnings Ratio-0.03--0.32--0.48--0.31--0.28--0.22-
Price-to-Total Gains Ratio0.06--0.49--0.38--0.26-7.86-6.45-
Price to Book Ratio0.29-0.55-0.07-0.23-0.28-0.21-
Price-to-Total Gains Ratio0.06--0.49--0.38--0.26-7.86-6.45-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5.34
Number of shares187
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share5.471.12
Usd Book Value Change Per Share1.49-0.41
Usd Total Gains Per Share6.970.70
Gains per Quarter (187 shares)1,302.71131.83
Gains per Year (187 shares)5,210.83527.33
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1409511165201835-308517
281902232104121671-6161044
3122853348156232506-9241571
4163804464208343342-12332098
5204745580260454177-15412625
6245696696312565013-18493152
7286647812364675848-21573679
8327598928416786684-24654206
93685410044468897519-27734733
104094911159521008355-30815260

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%1.011.00.08.3%1.019.00.05.0%1.039.00.02.5%4.086.00.04.4%
Book Value Change Per Share2.02.00.050.0%4.08.00.033.3%7.013.00.035.0%16.024.00.040.0%35.053.02.038.9%
Dividend per Share1.00.03.025.0%3.00.09.025.0%6.00.014.030.0%7.00.033.017.5%7.00.083.07.8%
Total Gains per Share2.02.00.050.0%4.08.00.033.3%7.013.00.035.0%16.024.00.040.0%35.053.02.038.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Applied DNA Sciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--5.3681.492+260%-3.911+173%-0.747+114%-0.412+108%0.050+10643%
Book Value Per Share--5.7662.429+137%4.607+25%7.807-26%12.542-54%13.330-57%
Current Ratio--4.4504.111+8%2.632+69%3.634+22%3.960+12%3.838+16%
Debt To Asset Ratio--0.2160.249-13%0.698-69%0.472-54%0.404-47%0.439-51%
Debt To Equity Ratio--0.2750.330-17%1.081-75%0.772-64%0.661-58%0.806-66%
Dividend Per Share--21.8985.474+300%0.001+1540175%1.843+1088%1.117+1861%0.559+3820%
Enterprise Value--6955127.76010255402.366-32%587699.406+1083%4702462.919+48%5714896.001+22%4292771.001+62%
Eps---15.354-3.789-75%-3.829-75%-3.714-76%-4.954-68%-5.051-67%
Ev To Ebitda Ratio---0.502-0.815+62%-0.064-87%-0.408-19%-0.508+1%-0.633+26%
Ev To Sales Ratio--1.7682.769-36%0.028+6228%0.999+77%1.364+30%1.100+61%
Free Cash Flow Per Share---1.901-0.773-59%-2.531+33%-2.195+15%-3.926+107%-3.947+108%
Free Cash Flow To Equity Per Share---1.3940.072-2037%-1.316-6%2.370-159%1.244-212%2.825-149%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.026-3%1.013-1%
Intrinsic Value_10Y_max---49.911----------
Intrinsic Value_10Y_min---177.914----------
Intrinsic Value_1Y_max---8.246----------
Intrinsic Value_1Y_min---16.237----------
Intrinsic Value_3Y_max---22.302----------
Intrinsic Value_3Y_min---50.452----------
Intrinsic Value_5Y_max---33.378----------
Intrinsic Value_5Y_min---86.233----------
Market Cap2771460.000-6%2943322.7605634965.116-48%2611132.156+13%2983969.169-1%2995240.001-2%2083259.601+41%
Net Profit Margin---27.684-7.897-71%-2.951-89%-3.706-87%-3.680-87%-3.307-88%
Operating Margin----2.6740%-3.7850%-2.3810%-2.8070%-2.8610%
Operating Ratio--4.5204.554-1%4.618-2%3.619+25%3.952+14%3.952+14%
Pb Ratio0.926+69%0.2880.555-48%0.073+297%0.234+23%0.276+4%0.210+37%
Pe Ratio-0.087-222%-0.027-0.323+1095%-0.482+1682%-0.306+1033%-0.283+947%-0.222+723%
Price Per Share5.340+69%1.6600.731+127%0.882+88%0.926+79%2.877-42%2.567-35%
Price To Free Cash Flow Ratio-0.702-222%-0.218-0.399+83%-0.201-8%-0.123-44%-0.203-7%-0.176-19%
Price To Total Gains Ratio0.196+69%0.061-0.493+909%-0.377+720%-0.264+534%7.860-99%6.453-99%
Quick Ratio--3.9663.674+8%2.347+69%3.266+21%3.539+12%3.490+14%
Return On Assets---2.088-0.600-71%-0.266-87%-0.313-85%-0.297-86%-0.301-86%
Return On Equity---2.663-0.770-71%-0.358-87%-0.425-84%-0.423-84%-0.557-79%
Total Gains Per Share--27.2666.966+291%-3.910+114%1.096+2388%0.705+3768%0.609+4380%
Usd Book Value--10224208.00010994098.000-7%4004874.250+155%8235515.667+24%9019622.600+13%8173208.400+25%
Usd Book Value Change Per Share--5.3681.492+260%-3.911+173%-0.747+114%-0.412+108%0.050+10643%
Usd Book Value Per Share--5.7662.429+137%4.607+25%7.807-26%12.542-54%13.330-57%
Usd Dividend Per Share--21.8985.474+300%0.001+1540175%1.843+1088%1.117+1861%0.559+3820%
Usd Enterprise Value--6955127.76010255402.366-32%587699.406+1083%4702462.919+48%5714896.001+22%4292771.001+62%
Usd Eps---15.354-3.789-75%-3.829-75%-3.714-76%-4.954-68%-5.051-67%
Usd Free Cash Flow---3370354.000-3487527.000+3%-2769046.750-18%-2713416.250-19%-2982112.150-12%-2520465.425-25%
Usd Free Cash Flow Per Share---1.901-0.773-59%-2.531+33%-2.195+15%-3.926+107%-3.947+108%
Usd Free Cash Flow To Equity Per Share---1.3940.072-2037%-1.316-6%2.370-159%1.244-212%2.825-149%
Usd Market Cap2771460.000-6%2943322.7605634965.116-48%2611132.156+13%2983969.169-1%2995240.001-2%2083259.601+41%
Usd Price Per Share5.340+69%1.6600.731+127%0.882+88%0.926+79%2.877-42%2.567-35%
Usd Profit---27223604.000-7819990.750-71%-3086340.250-89%-4064803.417-85%-3816283.800-86%-3236380.625-88%
Usd Revenue--983374.000947654.250+4%1379468.000-29%2236211.917-56%2346038.750-58%1814620.550-46%
Usd Total Gains Per Share--27.2666.966+291%-3.910+114%1.096+2388%0.705+3768%0.609+4380%
 EOD+4 -4MRQTTM+19 -19YOY+24 -143Y+19 -195Y+19 -2010Y+21 -18

3.3 Fundamental Score

Let's check the fundamental score of Applied DNA Sciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.087
Price to Book Ratio (EOD)Between0-10.926
Net Profit Margin (MRQ)Greater than0-27.684
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.966
Current Ratio (MRQ)Greater than14.450
Debt to Asset Ratio (MRQ)Less than10.216
Debt to Equity Ratio (MRQ)Less than10.275
Return on Equity (MRQ)Greater than0.15-2.663
Return on Assets (MRQ)Greater than0.05-2.088
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Applied DNA Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.498
Ma 20Greater thanMa 504.891
Ma 50Greater thanMa 1007.631
Ma 100Greater thanMa 20029.960
OpenGreater thanClose5.210
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Applied DNA Sciences Inc

Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR) for production and detection of DNA and RNA; and MDx test kits and related supplies, as well as Isotopic analysis testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, nutraceuticals, and other products; SigNify portable DNA readers and SigNify consumable reagent test kits; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. The company was founded in 1983 and is headquartered in Stony Brook, New York.

Fundamental data was last updated by Penke on 2025-07-10 20:52:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Applied DNA Sciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Applied DNA Sciences Inc to theΒ Diagnostics & Research industry mean.
  • A Net Profit Margin of -2,768.4%Β means thatΒ $-27.68 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Applied DNA Sciences Inc:

  • The MRQ is -2,768.4%. The company is making a huge loss. -2
  • The TTM is -789.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-2,768.4%TTM-789.7%-1,978.7%
TTM-789.7%YOY-295.1%-494.5%
TTM-789.7%5Y-368.0%-421.7%
5Y-368.0%10Y-330.7%-37.2%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-2,768.4%-5.0%-2,763.4%
TTM-789.7%-5.8%-783.9%
YOY-295.1%-9.0%-286.1%
3Y-370.6%-8.5%-362.1%
5Y-368.0%-4.9%-363.1%
10Y-330.7%-1.8%-328.9%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Applied DNA Sciences Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Applied DNA Sciences Inc to theΒ Diagnostics & Research industry mean.
  • -208.8% Return on Assets means thatΒ Applied DNA Sciences Inc generatedΒ $-2.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Applied DNA Sciences Inc:

  • The MRQ is -208.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -60.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-208.8%TTM-60.0%-148.9%
TTM-60.0%YOY-26.6%-33.3%
TTM-60.0%5Y-29.7%-30.3%
5Y-29.7%10Y-30.1%+0.5%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-208.8%-0.7%-208.1%
TTM-60.0%-0.8%-59.2%
YOY-26.6%-1.3%-25.3%
3Y-31.3%-1.4%-29.9%
5Y-29.7%-0.1%-29.6%
10Y-30.1%0.1%-30.2%
4.3.1.3. Return on Equity

Shows how efficient Applied DNA Sciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Applied DNA Sciences Inc to theΒ Diagnostics & Research industry mean.
  • -266.3% Return on Equity means Applied DNA Sciences Inc generated $-2.66Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Applied DNA Sciences Inc:

  • The MRQ is -266.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -77.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-266.3%TTM-77.0%-189.3%
TTM-77.0%YOY-35.8%-41.1%
TTM-77.0%5Y-42.3%-34.7%
5Y-42.3%10Y-55.7%+13.4%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-266.3%-0.8%-265.5%
TTM-77.0%-0.8%-76.2%
YOY-35.8%-2.0%-33.8%
3Y-42.5%-1.7%-40.8%
5Y-42.3%-1.1%-41.2%
10Y-55.7%-1.4%-54.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Applied DNA Sciences Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Applied DNA Sciences Inc is operatingΒ .

  • Measures how much profit Applied DNA Sciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Applied DNA Sciences Inc to theΒ Diagnostics & Research industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Applied DNA Sciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-267.4%+267.4%
TTM-267.4%YOY-378.5%+111.1%
TTM-267.4%5Y-280.7%+13.3%
5Y-280.7%10Y-286.1%+5.4%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.8%-4.8%
TTM-267.4%-10.7%-256.7%
YOY-378.5%-8.5%-370.0%
3Y-238.1%-1.7%-236.4%
5Y-280.7%3.2%-283.9%
10Y-286.1%4.0%-290.1%
4.3.2.2. Operating Ratio

Measures how efficient Applied DNA Sciences Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Diagnostics & Research industry mean).
  • An Operation Ratio of 4.52 means that the operating costs are $4.52 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Applied DNA Sciences Inc:

  • The MRQ is 4.520. The company is inefficient in keeping operating costs low. -1
  • The TTM is 4.554. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ4.520TTM4.554-0.034
TTM4.554YOY4.618-0.064
TTM4.5545Y3.952+0.602
5Y3.95210Y3.952+0.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ4.5201.375+3.145
TTM4.5541.302+3.252
YOY4.6181.292+3.326
3Y3.6191.284+2.335
5Y3.9521.277+2.675
10Y3.9521.192+2.760
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Applied DNA Sciences Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Applied DNA Sciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Diagnostics & Research industry mean).
  • A Current Ratio of 4.45Β means the company has $4.45 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Applied DNA Sciences Inc:

  • The MRQ is 4.450. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.111. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.450TTM4.111+0.339
TTM4.111YOY2.632+1.479
TTM4.1115Y3.960+0.151
5Y3.96010Y3.838+0.122
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ4.4502.037+2.413
TTM4.1112.055+2.056
YOY2.6322.374+0.258
3Y3.6342.414+1.220
5Y3.9602.552+1.408
10Y3.8382.974+0.864
4.4.3.2. Quick Ratio

Measures if Applied DNA Sciences Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Applied DNA Sciences Inc to theΒ Diagnostics & Research industry mean.
  • A Quick Ratio of 3.97Β means the company can pay off $3.97 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Applied DNA Sciences Inc:

  • The MRQ is 3.966. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.674. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.966TTM3.674+0.292
TTM3.674YOY2.347+1.327
TTM3.6745Y3.539+0.135
5Y3.53910Y3.490+0.049
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ3.9661.084+2.882
TTM3.6741.132+2.542
YOY2.3471.354+0.993
3Y3.2661.538+1.728
5Y3.5391.803+1.736
10Y3.4902.090+1.400
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Applied DNA Sciences Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Applied DNA Sciences IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Applied DNA Sciences Inc to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.22Β means that Applied DNA Sciences Inc assets areΒ financed with 21.6% credit (debt) and the remaining percentage (100% - 21.6%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Applied DNA Sciences Inc:

  • The MRQ is 0.216. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.249. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.216TTM0.249-0.033
TTM0.249YOY0.698-0.449
TTM0.2495Y0.404-0.155
5Y0.40410Y0.439-0.035
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2160.385-0.169
TTM0.2490.432-0.183
YOY0.6980.390+0.308
3Y0.4720.389+0.083
5Y0.4040.410-0.006
10Y0.4390.454-0.015
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Applied DNA Sciences Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Applied DNA Sciences Inc to theΒ Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 27.5% means that company has $0.27 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Applied DNA Sciences Inc:

  • The MRQ is 0.275. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.330. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.275TTM0.330-0.055
TTM0.330YOY1.081-0.751
TTM0.3305Y0.661-0.331
5Y0.66110Y0.806-0.145
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2750.604-0.329
TTM0.3300.612-0.282
YOY1.0810.589+0.492
3Y0.7720.702+0.070
5Y0.6610.674-0.013
10Y0.8060.657+0.149
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Applied DNA Sciences Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ Applied DNA Sciences Inc to theΒ Diagnostics & Research industry mean.
  • A PE ratio of -0.03 means the investor is paying $-0.03Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Applied DNA Sciences Inc:

  • The EOD is -0.087. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.027. Based on the earnings, the company is expensive. -2
  • The TTM is -0.323. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.087MRQ-0.027-0.060
MRQ-0.027TTM-0.323+0.296
TTM-0.323YOY-0.482+0.159
TTM-0.3235Y-0.283-0.040
5Y-0.28310Y-0.222-0.060
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-0.087-0.557+0.470
MRQ-0.027-0.732+0.705
TTM-0.323-0.475+0.152
YOY-0.482-0.128-0.354
3Y-0.306-0.087-0.219
5Y-0.2835.675-5.958
10Y-0.2227.829-8.051
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Applied DNA Sciences Inc:

  • The EOD is -0.702. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.218. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.399. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.702MRQ-0.218-0.484
MRQ-0.218TTM-0.399+0.181
TTM-0.399YOY-0.201-0.198
TTM-0.3995Y-0.203-0.196
5Y-0.20310Y-0.176-0.027
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-0.702-1.022+0.320
MRQ-0.218-1.081+0.863
TTM-0.399-0.557+0.158
YOY-0.201-1.055+0.854
3Y-0.123-0.440+0.317
5Y-0.203-0.670+0.467
10Y-0.176-0.655+0.479
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Applied DNA Sciences Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 0.29 means the investor is paying $0.29Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Applied DNA Sciences Inc:

  • The EOD is 0.926. Based on the equity, the company is cheap. +2
  • The MRQ is 0.288. Based on the equity, the company is cheap. +2
  • The TTM is 0.555. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.926MRQ0.288+0.638
MRQ0.288TTM0.555-0.267
TTM0.555YOY0.073+0.482
TTM0.5555Y0.276+0.279
5Y0.27610Y0.210+0.066
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD0.9262.088-1.162
MRQ0.2882.072-1.784
TTM0.5552.188-1.633
YOY0.0732.305-2.232
3Y0.2342.476-2.242
5Y0.2763.475-3.199
10Y0.2104.360-4.150
4.6.2. Total Gains per Share

2.4. Latest News of Applied DNA Sciences Inc

Does Applied DNA Sciences Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Applied DNA Sciences Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-07-07
15:19
Applied DNA Sciences regains Nasdaq complianceRead
2025-07-07
15:00
Applied DNA Regains Compliance with All Nasdaq Continued Listing RequirementsRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Applied DNA Sciences Inc.

4.8.1. Institutions holding Applied DNA Sciences Inc

Institutions are holding 4.118% of the shares of Applied DNA Sciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31Anson Funds Management LP2.6930.06342100542100540
2025-03-31UBS Group AG0.4443034656346541732700
2024-12-31Sanctuary Advisors, LLC0.0039015300153000
2025-03-31PFG Investments, LLC0.16030.001312500125000
2025-03-31Barclays PLC0.01540120312030
2025-03-31SBI Securities Co Ltd0.01280.00011002-1347-57.3436
2025-03-31Tower Research Capital LLC0.00620486272127.1028
2025-03-31BlackRock Inc0.0008059-42-41.5842
2025-03-31Federation des caisses Desjardins du Quebec0.0006050500
2025-03-31Natixis SA0.0001011-3-21.4286
2025-03-31Bank of America Corp0.000109112.5
2025-03-31Wells Fargo & Co0.000104133.3333
2025-03-31Morgan Stanley - Brokerage Accounts0.00010440
2025-03-31Activest Wealth Management003150
2025-03-31Advisor Group Holdings, Inc.00220
2025-03-31Royal Bank of Canada00200
2025-03-31Westside Investment Management, Inc.00200
2025-03-31Mccormack Advisors International00220
2025-03-31Wealth Preservation Advisors00110
2025-03-31Country Trust Bank00110
Total 3.33770.0648275351+272654+99.0%

4.9.2. Funds holding Applied DNA Sciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-04-30Fidelity Extended Market Index0.08510663400
2025-04-30Fidelity Series Total Market Index0.01810141010.071
2025-04-30Fidelity Total Market Index0.0067052110.1923
2025-05-31Vanguard Institutional Extnd Mkt Idx Tr0.0022017400
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T4001401400
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T3001401400
2025-03-31Extended Equity Market Fund K0.000503700
2025-03-31Northern Trust Extended Eq Market Idx0.000201200
2025-03-31NT Ext Equity Mkt Idx Fd - L0.000201200
2025-05-31State St US Extended Mkt Indx NL Cl C0.000101000
2025-03-31Extended Equity Market Fund M0.00010500
2025-03-31NT Ext Equity Mkt Idx Fd - NL0.000104133.3333
2025-03-31SSgA U.S. Total Market Index Strategy0.00010400
2025-03-31NT Ext Eq Mkt Indx Fd DC Lending Tier 500300
2025-03-31NT Ext Equity Mkt Idx Fd - DC - NL - T200300
2025-04-30Fidelity U.S. Equity Index Ins Trust00110
Total 0.113409110+284+3.1%

5.3. Insider Transactions

Insiders are holding 2.759% of the shares of Applied DNA Sciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2020-06-26William W MontgomeryBUY1100005.25135000
2020-06-18William W MontgomeryBUY400005.25215000
2020-06-09William W MontgomeryBUY750005.25140000
2019-11-13William W. MontgomeryBUY750005.24
2019-09-16William W MontgomeryBUY66780.366024222
2019-08-22William W MontgomeryBUY4000000.275630900
2019-01-24William W MontgomeryBUY500000.475180900
2019-01-22William W MontgomeryBUY600000.445030900
2019-01-18William W MontgomeryBUY1000000.445030900
2019-01-07William W MontgomeryBUY4000000.454560900
2019-01-03William W MontgomeryBUY1540000.444560900
2018-12-31William W MontgomeryBUY300000.374560900
2014-11-20James A HaywardBUY769233.24
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets13,036
Total Liabilities2,811
Total Stockholder Equity10,224
 As reported
Total Liabilities 2,811
Total Stockholder Equity+ 10,224
Total Assets = 13,036

Assets

Total Assets13,036
Total Current Assets8,430
Long-term Assets4,605
Total Current Assets
Cash And Cash Equivalents 6,823
Net Receivables 690
Inventory 349
Other Current Assets 568
Total Current Assets  (as reported)8,430
Total Current Assets  (calculated)8,430
+/-0
Long-term Assets
Property Plant Equipment 1,156
Intangible Assets 2,699
Long-term Assets Other 750
Long-term Assets  (as reported)4,605
Long-term Assets  (calculated)4,605
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,894
Long-term Liabilities917
Total Stockholder Equity10,224
Total Current Liabilities
Short-term Debt 472
Accounts payable 885
Other Current Liabilities 1,410
Total Current Liabilities  (as reported)1,894
Total Current Liabilities  (calculated)2,767
+/- 873
Long-term Liabilities
Capital Lease Obligations 472
Long-term Liabilities  (as reported)917
Long-term Liabilities  (calculated)472
+/- 445
Total Stockholder Equity
Common Stock6
Retained Earnings -354,443
Other Stockholders Equity 364,661
Total Stockholder Equity (as reported)10,224
Total Stockholder Equity (calculated)10,224
+/-0
Other
Capital Stock6
Cash and Short Term Investments 6,823
Common Stock Shares Outstanding 1,773
Current Deferred Revenue12
Liabilities and Stockholders Equity 13,036
Net Debt -6,351
Net Invested Capital 10,460
Net Working Capital 6,536
Property Plant and Equipment Gross 1,156
Short Long Term Debt Total 472



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-31
> Total Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34
98
207
895
277
85
82
82
3,071
1,295
9,183
8,987
8,586
11,694
9,183
3,580
2,460
2,203
2,412
3,337
2,563
2,563
1,847
1,533
1,799
1,550
1,507
1,133
1,070
1,020
1,413
1,774
1,238
894
3,504
2,522
1,452
1,970
1,349
1,625
5,073
3,841
8,375
6,241
3,782
3,771
3,506
5,022
3,627
14,123
15,554
20,485
17,712
15,219
15,566
16,770
13,217
10,423
8,154
9,609
7,934
6,608
5,634
6,149
4,226
2,985
3,565
10,872
11,327
13,975
11,341
9,678
20,782
17,190
14,417
11,402
13,879
11,920
22,265
20,297
19,175
15,790
13,652
9,913
9,176
16,690
12,789
15,971
13,036
13,03615,97112,78916,6909,1769,91313,65215,79019,17520,29722,26511,92013,87911,40214,41717,19020,7829,67811,34113,97511,32710,8723,5652,9854,2266,1495,6346,6087,9349,6098,15410,42313,21716,77015,56615,21917,71220,48515,55414,1233,6275,0223,5063,7713,7826,2418,3753,8415,0731,6251,3491,9701,4522,5223,5048941,2381,7741,4131,0201,0701,1331,5071,5501,7991,5331,8472,5632,5633,3372,4122,2032,4603,5809,18311,6948,5868,9879,1831,2953,07182828527789520798340000000000000000
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
26
79
193
624
198
0
2
2
2,975
1,192
44
182
81
2,108
44
739
116
174
526
1,223
789
789
295
174
564
357
340
74
160
181
242
638
274
293
3,032
2,218
1,204
1,807
1,102
1,399
4,839
2,561
7,207
5,075
2,702
2,715
2,363
4,135
2,300
13,018
11,535
16,494
14,939
12,143
11,352
13,314
9,749
8,144
6,241
7,774
6,104
4,828
4,002
4,600
2,763
1,605
2,146
9,638
9,979
12,155
9,078
6,540
17,419
13,696
11,298
8,499
11,156
9,268
19,943
18,332
15,380
12,240
8,127
4,590
4,365
11,842
8,048
11,276
8,430
8,43011,2768,04811,8424,3654,5908,12712,24015,38018,33219,9439,26811,1568,49911,29813,69617,4196,5409,07812,1559,9799,6382,1461,6052,7634,6004,0024,8286,1047,7746,2418,1449,74913,31411,35212,14314,93916,49411,53513,0182,3004,1352,3632,7152,7025,0757,2072,5614,8391,3991,1021,8071,2042,2183,032293274638242181160743403575641742957897891,223526174116739442,10881182441,1922,97522019862419379260000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
26
79
193
624
198
0
2
2
2,975
1,192
31
165
78
1,931
31
653
89
35
25
846
585
585
136
51
14
17
213
6
99
22
18
468
123
12
2,747
1,936
857
1,256
725
984
4,406
1,832
6,360
4,199
1,988
2,026
1,393
2,872
984
10,730
7,312
12,383
9,786
7,087
4,479
6,702
4,020
2,403
2,960
4,765
3,709
2,515
1,660
3,138
1,541
507
559
8,663
8,663
10,925
7,787
4,241
13,926
12,173
6,555
2,748
6,513
4,682
15,215
12,877
12,287
10,756
7,152
3,359
3,150
10,442
6,431
9,294
6,823
6,8239,2946,43110,4423,1503,3597,15210,75612,28712,87715,2154,6826,5132,7486,55512,17313,9264,2417,78710,9258,6638,6635595071,5413,1381,6602,5153,7094,7652,9602,4034,0206,7024,4797,0879,78612,3837,31210,7309842,8721,3932,0261,9884,1996,3601,8324,4069847251,2568571,9362,747121234681822996213171451136585585846253589653311,93178165311,1922,97522019862419379260000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
17
3
31
12
19
0
0
0
14
89
89
75
71
64
16
47
16
36
57
63
63
99
178
209
233
324
443
297
362
408
588
673
749
606
518
835
1,115
1,160
2,078
3,930
3,924
5,027
4,792
6,375
6,156
5,192
5,251
2,588
2,156
1,526
1,415
1,486
615
316
244
840
274
549
231
194
1,034
2,186
737
2,804
3,857
2,588
2,859
3,068
4,053
1,968
683
256
451
409
514
362
912
690
6909123625144094512566831,9684,0533,0682,8592,5883,8572,8047372,1861,0341942315492748402443166151,4861,4151,5262,1562,5885,2515,1926,1566,3754,7925,0273,9243,9302,0781,1601,11583551860674967358840836229744332423320917899636357361647166471758989140001912313171200000000000000000000000000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
147
107
67
27
139
0
363
115
115
83
52
486
323
79
52
25
103
161
106
52
103
76
50
24
108
80
52
51
142
348
253
216
171
135
149
311
420
293
375
253
274
400
266
366
113
734
1,080
1,151
1,206
1,270
1,244
1,182
1,089
605
1,236
1,356
1,109
1,199
1,442
1,172
713
569
1,186
1,288
1,109
1,058
925
759
525
389
403
470
416
816
602
568
5686028164164704033895257599251,0581,1091,2881,1865697131,1721,4421,1991,1091,3561,2366051,0891,1821,2441,2701,2061,1511,0807341133662664002742533752934203111491351712162533481425152801082450761035210616110325527932348652831151153630139276710714700000000000000000000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
19
14
271
79
85
80
80
96
102
9,139
8,805
8,505
9,585
9,139
2,841
2,344
2,030
0
2,115
1,774
1,774
1,552
1,359
1,234
1,193
1,167
1,059
911
838
1,171
1,137
964
601
471
303
248
164
247
226
234
1,280
1,168
1,165
1,080
1,056
1,143
887
1,327
1,106
4,019
3,990
2,773
3,076
4,214
3,455
3,468
2,279
1,913
1,835
1,829
1,780
1,632
1,549
1,463
1,380
1,418
1,234
1,348
1,820
2,263
3,138
3,362
3,493
3,119
2,903
2,724
2,652
2,322
1,965
3,796
3,549
5,525
5,323
4,811
4,848
4,741
4,695
4,605
4,6054,6954,7414,8484,8115,3235,5253,5493,7961,9652,3222,6522,7242,9033,1193,4933,3623,1382,2631,8201,3481,2341,4181,3801,4631,5491,6321,7801,8291,8351,9132,2793,4683,4554,2143,0762,7733,9904,0191,1061,3278871,1431,0561,0801,1651,1681,2802342262471642483034716019641,1371,1718389111,0591,1671,1931,2341,3591,5521,7741,7742,11502,0302,3442,8419,1399,5858,5058,8059,1391029680808579271141980000000000000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
29
29
28
28
28
22
21
8
4
42
38
8
152
137
121
106
96
81
81
64
47
33
19
12
9
8
6
4
2
1
4
89
82
121
127
211
190
198
664
696
717
647
649
576
521
588
527
572
562
879
806
792
724
672
590
524
500
551
536
420
369
316
265
226
184
265
751
1,278
2,175
2,423
2,577
3,024
2,808
2,629
2,557
2,223
1,866
3,046
2,524
2,076
1,657
1,362
1,399
1,292
1,246
1,156
1,1561,2461,2921,3991,3621,6572,0762,5243,0461,8662,2232,5572,6292,8083,0242,5772,4232,1751,2787512651842262653163694205365515005245906727247928068795625725275885215766496477176966641981902111271218289412468912193347648181961061211371528384248212228282829290000000000000000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
14
18
27
33
28
28
26
25
9,117
8,778
8,440
8,101
2,107
2,015
1,922
1,829
1,737
1,644
1,459
1,459
1,367
1,275
1,183
1,092
1,001
909
819
728
637
546
0
364
273
182
91
0
0
0
0
565
421
397
375
351
328
304
389
526
285
285
285
285
285
285
285
285
285
285
285
285
285
285
285
285
285
285
285
285
285
285
285
285
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000028528528528528528528528528528528528528528528528528528528528528528528528552638930432835137539742156500009118227336405466377288199091,0011,0921,1831,2751,3671,4591,4591,6441,7371,8291,9222,0152,1078,1018,4408,7789,1172526282833271814400000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,500
1,500
0
360
1,535
920
1,045
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000001,0459201,53536001,5001,500000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
14
18
27
33
28
28
26
25
9,117
8,778
8,440
8,101
9,117
2,015
1,922
1,829
1,737
1,644
1,459
1,459
1,367
1,275
1,183
1,092
1,001
909
819
728
637
546
0
364
273
182
91
0
0
0
0
565
421
397
375
351
328
304
389
526
1,599
1,584
1,549
1,564
1,526
1,465
1,404
1,343
1,042
986
930
897
864
832
799
767
735
702
721
689
605
582
559
536
0
0
0
0
0
0
0
0
2,699
2,699
2,699
2,699
2,699
2,699
2,699
2,6992,6992,6992,6992,6992,6992,699000000005365595826056897217027357677998328648979309861,0421,3431,4041,4651,5261,5641,5491,5841,59952638930432835137539742156500009118227336405466377288199091,0011,0921,1831,2751,3671,4591,4591,6441,7371,8291,9222,0159,1178,1018,4408,7789,1172526282833271814400000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
222
127
36
36
36
36
616
472
449
433
407
567
366
739
579
3,447
3,429
1,894
2,270
3,422
2,732
2,796
1,689
1,389
1,334
62
62
62
62
62
62
172
62
76
95
95
95
95
95
95
95
95
95
99
99
0
1,026
0
0
0
0
0
0
0
00000001,0260999995959595959595959576621726262626262621,3341,3891,6892,7962,7323,4222,2701,8943,4293,44757973936656740743344947261636363636127222000000000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
288
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
110
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000110000000000000000002880000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
1
1
1
1
1
1
1
0
0
0
0
0
119
178
349
785
895
1,406
2,121
4,788
4,788
2,292
1,545
2,596
4,158
10,252
14,096
2,596
13,427
21,677
15,191
14,356
14,897
16,007
16,007
15,884
13,863
1,995
2,470
3,254
4,017
4,197
3,536
3,011
3,578
3,362
4,868
4,499
3,876
638
654
592
8,323
8,844
1,533
3,759
4,358
4,103
3,460
4,975
1,721
1,671
1,623
2,987
2,489
2,684
3,033
5,200
4,588
3,926
2,405
1,296
1,470
2,226
3,550
4,879
5,383
4,960
4,774
4,413
3,648
4,058
5,196
5,632
3,955
2,162
1,606
3,304
3,010
6,233
5,126
9,356
11,139
9,207
8,595
8,779
5,785
9,351
4,456
3,821
3,421
2,811
2,8113,4213,8214,4569,3515,7858,7798,5959,20711,1399,3565,1266,2333,0103,3041,6062,1623,9555,6325,1964,0583,6484,4134,7744,9605,3834,8793,5502,2261,4701,2962,4053,9264,5885,2003,0332,6842,4892,9871,6231,6711,7214,9753,4604,1034,3583,7591,5338,8448,3235926546383,8764,4994,8683,3623,5783,0113,5364,1974,0173,2542,4701,99513,86315,88416,00716,00714,89714,35615,19121,67713,4272,59614,09610,2524,1582,5961,5452,2924,7884,7882,1211,406895785349178119000001111111000
   > Total Current Liabilities 
0
0
0
1
0
0
0
1
1
1
0
0
0
0
0
119
178
260
696
806
1,317
2,032
4,788
4,788
2,292
1,545
2,596
4,158
2,787
5,091
2,596
10,995
12,857
10,723
14,356
14,897
16,007
16,007
15,884
13,863
1,995
2,470
3,254
4,017
4,197
2,880
2,792
3,358
3,362
4,868
4,499
3,876
638
654
592
809
810
1,533
1,115
1,535
1,735
1,608
3,878
1,721
1,671
1,623
2,667
2,169
2,684
3,033
4,085
3,993
3,221
2,405
1,296
1,470
2,226
3,117
2,822
2,733
2,220
1,974
2,246
1,509
1,850
2,448
4,266
2,919
2,130
1,575
3,272
2,979
3,633
4,284
4,185
3,330
3,655
2,891
2,845
2,588
2,623
3,026
2,398
2,387
1,894
1,8942,3872,3983,0262,6232,5882,8452,8913,6553,3304,1854,2843,6332,9793,2721,5752,1302,9194,2662,4481,8501,5092,2461,9742,2202,7332,8223,1172,2261,4701,2962,4053,2213,9934,0853,0332,6842,1692,6671,6231,6711,7213,8781,6081,7351,5351,1151,5338108095926546383,8764,4994,8683,3623,3582,7922,8804,1974,0173,2542,4701,99513,86315,88416,00716,00714,89714,35610,72312,85710,9952,5965,0912,7874,1582,5961,5452,2924,7884,7882,0321,317806696260178119000001110001000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
133
661
1,219
2,789
2,789
425
425
410
960
510
410
410
4,217
4,931
1,746
740
2,237
3,169
3,169
3,063
1,068
927
1,529
2,410
2,809
2,447
1,645
1,774
2,407
2,424
2,952
3,731
3,088
250
250
0
0
0
0
0
0
0
0
1,800
1,800
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
376
1,828
659
0
0
0
0
0
-757
0
0
953
975
499
1,020
522
1,067
1,092
1,117
472
4721,1171,0921,0675221,02049997595300-757000006591,8283760000000000000000000001,8001,800000000002502503,0883,7312,9522,4242,4071,7741,6452,4472,8092,4101,5299271,0683,0633,1693,1692,2377401,7464,9314,2174104105109604104254252,7892,7891,2196611330000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,800
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
376
1,828
659
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000006591,82837600000000000000000000001,80000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
1
0
0
0
0
1
1
0
0
0
0
0
101
106
156
454
393
429
567
1,770
1,770
1,654
933
2,185
3,144
2,274
4,681
2,185
6,777
7,926
8,977
0
235
12,778
12,778
413
583
737
752
593
750
828
962
721
0
0
721
165
287
257
214
473
603
685
1,249
641
770
986
905
1,060
886
998
770
1,238
1,599
1,909
1,479
1,530
1,658
1,158
1,016
383
602
439
387
501
944
642
839
1,152
833
700
1,131
1,250
1,518
1,217
716
2,010
1,761
1,437
1,842
1,744
2,023
1,647
1,052
1,072
1,017
1,128
1,599
1,166
1,234
885
8851,2341,1661,5991,1281,0171,0721,0521,6472,0231,7441,8421,4371,7612,0107161,2171,5181,2501,1317008331,1528396429445013874396023831,0161,1581,6581,5301,4791,9091,5991,2387709988861,0609059867706411,2496856034732142572871657210072196282875059375273758341312,77812,77823508,9777,9266,7772,1854,6812,2743,1442,1859331,6541,7701,770567429393454156106101000001100001000
       Other Current Liabilities 
0
0
0
0
0
0
0
0
-1
-1
0
0
0
0
0
18
72
105
242
280
227
245
229
229
213
186
0
54
2
0
231
5,225
0
8,977
0
12,425
0
0
12,408
12,213
331
189
250
458
922
272
296
951
939
1,916
603
500
131
165
119
206
125
285
326
440
333
355
1,018
311
446
648
1,147
512
725
705
717
543
738
714
561
525
583
432
464
414
373
332
465
221
478
509
676
377
563
606
981
761
1,802
1,686
1,878
1,033
1,085
1,101
1,198
895
922
1,427
746
454
1,410
1,4104547461,4279228951,1981,1011,0851,0331,8781,6861,8027619816065633776765094782214653323734144644325835255617147385437177057255121,1476484463111,0183553334403262851252061191651315006031,91693995129627292245825018933112,21312,4080012,42508,97705,22523102540186213229229245227280242105721800000-1-100000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
1
1
0
0
0
0
0
101
106
89
89
89
89
89
0
4,559
2,079
1,358
0
2,596
7,464
9,005
4,531
2,432
8,820
4,468
0
4,468
16,007
16,007
3,477
1,651
1,664
2,281
3,003
3,559
3,275
656
220
221
2,424
220
3,896
3,375
507
489
473
7,514
8,034
1,249
2,643
2,823
2,367
1,852
1,096
1,410
1,225
975
320
320
1,959
2,328
1,116
595
705
1,691
735
945
1,644
433
2,057
2,650
2,741
2,800
2,167
2,139
2,208
2,748
1,366
1,036
31
31
31
31
2,599
841
5,171
7,809
5,552
5,704
5,934
3,197
6,728
1,430
1,423
1,034
917
9171,0341,4231,4306,7283,1975,9345,7045,5527,8095,1718412,599313131311,0361,3662,7482,2082,1392,1672,8002,7412,6502,0574331,6449457351,6917055951,1162,3281,9593203209751,2251,4101,0961,8522,3672,8232,6431,2498,0347,5144734895073,3753,8962202,4242212206563,2753,5593,0032,2811,6641,6513,47716,00716,0074,46804,4688,8202,4324,5319,0057,4642,59601,3582,0794,55908989898989106101000001100000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
320
0
0
0
0
0
0
0
0
0
0
0
1,587
2,141
2,195
2,216
1,442
1,479
1,486
1,963
517
188
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000001885171,9631,4861,4791,4422,2162,1952,1411,58700000000000320000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
288
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
110
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000110000000000000000002880000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,514
8,034
0
2,643
2,824
2,367
1,852
1,096
0
0
0
320
320
0
0
1,116
595
705
0
0
0
0
433
471
508
546
584
622
660
723
785
848
848
31
31
31
31
2,599
841
5,171
7,809
0
4,836
0
0
0
0
0
0
0
00000004,83607,8095,1718412,5993131313184884878572366062258454650847143300007055951,116003203200001,0961,8522,3672,8242,64308,0347,5140000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
900
468
564
0
0
0
0
0
0
0
0
0
110
0
0
0
0
0
0
0
0
0
0
0
0
0
0
276
0
0
0
0
0
0
0
0000000276000000000000001100000000005644689000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
-1
0
0
0
0
-1
-1
0
0
0
0
0
-119
-144
-251
-577
0
-1,128
-2,036
-4,707
-4,707
779
-250
6,587
4,829
-1,665
-2,402
6,587
-9,847
-19,217
-12,987
0
-11,560
-13,444
-13,444
-14,038
-12,330
-196
-920
-1,747
-2,884
-3,127
-2,517
-1,598
-1,804
-2,124
-3,974
-995
-1,354
814
1,316
757
-6,698
-3,771
2,308
4,616
1,882
-320
311
-1,468
3,301
1,955
12,500
12,567
17,996
15,028
12,186
10,365
12,182
9,291
8,018
6,858
8,138
5,707
3,058
755
766
-734
-1,789
-841
7,231
7,275
8,785
5,718
5,729
18,626
15,588
11,114
8,392
7,647
6,796
12,912
9,162
10,009
7,249
4,951
4,232
-48
12,392
9,143
12,753
10,224
10,22412,7539,14312,392-484,2324,9517,24910,0099,16212,9126,7967,6478,39211,11415,58818,6265,7295,7188,7857,2757,231-841-1,789-7347667553,0585,7078,1386,8588,0189,29112,18210,36512,18615,02817,99612,56712,5001,9553,301-1,468311-3201,8824,6162,308-3,771-6,6987571,316814-1,354-995-3,974-2,124-1,804-1,598-2,517-3,127-2,884-1,747-920-196-12,330-14,038-13,444-13,444-11,5600-12,987-19,217-9,8476,587-2,402-1,6654,8296,587-250779-4,707-4,707-2,036-1,1280-577-251-144-11900000-1-10000-1000
   Common Stock
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
2
2
2
10,225
10,451
11,044
11,991
11,991
67
66
112
113
119
119
112
121
121
160
0
191
197
197
205
238
261
262
275
275
297
334
346
350
352
353
473
513
591
627
646
657
684
734
787
808
809
827
14
17
17
21
22
24
24
24
24
26
26
27
27
30
30
30
30
36
38
38
1
3
4
5
5
6
7
7
7
7
8
9
13
13
13
13
14
14
1
10
10
54
6
6541010114141313131398777765543138383630303030272726262424242422211717148278098087877346846576466275915134733533523503463342972752752622612382051971971910160121121112119119113112666711,99111,99111,04410,45110,2252221111110000000000
   Retained Earnings Total Equity000000000000000-279,611-276,162-274,645-269,836-265,713-262,423-259,471-256,806-255,272-253,794-251,107-248,366-244,891-242,003-239,857-236,673-233,818-231,208-227,779-223,817-221,402-218,035-214,568-211,641-211,145-209,474-207,589-199,760-197,655-195,736-192,985-186,6940000000-161,856-157,4390000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-57
-3
55
300
104
-2
-1
-1
-1
-880
-37
20
-200
-200
-200
20
-21
-52
-67
-83
-83
-130
-130
-147
-164
-178
-192
-199
-201
-203
-205
-207
-209
-210
-211
-211
-218
-226
-238
-252
-273
-295
-338
-410
-492
-576
-666
0
0
-646
-744
0
-956
-1,039
-1,161
0
-1,364
-1,465
-1,000
-1,666
-1,666
0
0
-2,036
-2,036
0
0
-2,293
-2,293
0
0
0
0
294,789
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000294,7890000-2,293-2,29300-2,036-2,03600-1,666-1,666-1,000-1,465-1,3640-1,161-1,039-9560-744-64600-666-576-492-410-338-295-273-252-238-226-218-211-211-210-209-207-205-203-201-199-192-178-164-147-130-130-83-83-67-52-2120-200-200-20020-37-880-1-1-1-210430055-3-57000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
153,112
160,388
0
0
0
0
0
0
0
190,523
194,060
194,607
197,139
198,278
210,872
211,412
223,624
224,187
232,539
233,039
233,564
234,159
239,934
240,472
242,809
243,504
247,965
247,680
247,919
249,090
251,838
253,022
253,445
255,963
266,699
269,694
274,493
275,549
280,369
294,781
295,191
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000295,191294,781280,369275,549274,493269,694266,699255,963253,445253,022251,838249,090247,919247,680247,965243,504242,809240,472239,934234,159233,564233,039232,539224,187223,624211,412210,872198,278197,139194,607194,060190,5230000000160,388153,1120000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
806
0
0
0
0
806
806
815
815
815
815
815
96
465
627
2,578
671
1,858
2,588
6,119
6,119
101,124
54,355
81,880
82,786
88,221
81,861
81,880
83,038
83,038
87,420
0
130,956
131,924
131,919
133,339
138,124
140,198
140,803
141,410
142,081
143,205
146,709
149,397
150,532
152,808
153,112
160,388
162,399
166,033
167,929
169,118
170,357
176,385
184,549
191,297
194,060
194,607
197,139
198,278
210,872
211,412
223,624
224,187
232,539
233,039
233,564
234,159
239,934
240,472
242,809
243,504
247,965
247,680
247,919
249,090
251,838
253,022
253,445
255,963
266,699
269,694
274,493
275,549
280,369
294,781
295,191
295,228
297,228
298,352
298,624
305,399
305,493
305,751
306,091
307,385
307,849
308,207
318,758
318,805
339,919
364,661
364,661339,919318,805318,758308,207307,849307,385306,091305,751305,493305,399298,624298,352297,228295,228295,191294,781280,369275,549274,493269,694266,699255,963253,445253,022251,838249,090247,919247,680247,965243,504242,809240,472239,934234,159233,564233,039232,539224,187223,624211,412210,872198,278197,139194,607194,060191,297184,549176,385170,357169,118167,929166,033162,399160,388153,112152,808150,532149,397146,709143,205142,081141,410140,803140,198138,124133,339131,919131,924130,956087,42083,03883,03881,88081,86188,22182,78681,88054,355101,1246,1196,1192,5881,8586712,578627465968158158158158158068060000806000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-09-30. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue3,431
Cost of Revenue-2,415
Gross Profit1,0171,017
 
Operating Income (+$)
Gross Profit1,017
Operating Expense-15,042
Operating Income-14,025-14,025
 
Operating Expense (+$)
Research Development3,594
Selling General Administrative11,448
Selling And Marketing Expenses0
Operating Expense15,04215,042
 
Net Interest Income (+$)
Interest Income176
Interest Expense-0
Other Finance Cost-0
Net Interest Income176
 
Pretax Income (+$)
Operating Income-14,025
Net Interest Income176
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-7,088-20,961
EBIT - interestExpense = -14,025
-6,855
-6,993
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-14,025-7,088
Earnings Before Interest and Taxes (EBITDA)-13,328
 
After tax Income (+$)
Income Before Tax-7,088
Tax Provision-0
Net Income From Continuing Ops-7,088-7,088
Net Income-6,993
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses17,456
Total Other Income/Expenses Net6,936-176
 

Technical Analysis of Applied DNA Sciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Applied DNA Sciences Inc. The general trend of Applied DNA Sciences Inc is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Applied DNA Sciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Applied DNA Sciences Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Applied DNA Sciences Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 5.5 < 10.85 < 13.95.

The bearish price targets are: 4.4 > 4.4 > 4.38.

Know someone who trades $APDN? Share this with them.πŸ‘‡

Applied DNA Sciences Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Applied DNA Sciences Inc. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Applied DNA Sciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Applied DNA Sciences Inc. The current macd is -0.8172123.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Applied DNA Sciences Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Applied DNA Sciences Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Applied DNA Sciences Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Applied DNA Sciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartApplied DNA Sciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Applied DNA Sciences Inc. The current adx is 23.20.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Applied DNA Sciences Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Applied DNA Sciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Applied DNA Sciences Inc. The current sar is 4.43028804.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Applied DNA Sciences Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Applied DNA Sciences Inc. The current rsi is 43.50. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Applied DNA Sciences Inc Daily Relative Strength Index (RSI) ChartApplied DNA Sciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Applied DNA Sciences Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Applied DNA Sciences Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Applied DNA Sciences Inc Daily Stochastic Oscillator ChartApplied DNA Sciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Applied DNA Sciences Inc. The current cci is 126.32.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Applied DNA Sciences Inc Daily Commodity Channel Index (CCI) ChartApplied DNA Sciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Applied DNA Sciences Inc. The current cmo is 6.77780914.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Applied DNA Sciences Inc Daily Chande Momentum Oscillator (CMO) ChartApplied DNA Sciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Applied DNA Sciences Inc. The current willr is -24.40349634.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Applied DNA Sciences Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Applied DNA Sciences Inc Daily Williams %R ChartApplied DNA Sciences Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Applied DNA Sciences Inc.

Applied DNA Sciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Applied DNA Sciences Inc. The current atr is 0.73550334.

Applied DNA Sciences Inc Daily Average True Range (ATR) ChartApplied DNA Sciences Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Applied DNA Sciences Inc. The current obv is 376,927.

Applied DNA Sciences Inc Daily On-Balance Volume (OBV) ChartApplied DNA Sciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Applied DNA Sciences Inc. The current mfi is 71.00.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Applied DNA Sciences Inc Daily Money Flow Index (MFI) ChartApplied DNA Sciences Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Applied DNA Sciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-02-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-04MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-20MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-25MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-26STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-21STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-02ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-03STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-04STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-06-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Applied DNA Sciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Applied DNA Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.498
Ma 20Greater thanMa 504.891
Ma 50Greater thanMa 1007.631
Ma 100Greater thanMa 20029.960
OpenGreater thanClose5.210
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Applied DNA Sciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Applied DNA Sciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Applied DNA Sciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Applied DNA Sciences Inc

I send you an email if I find something interesting about Applied DNA Sciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Applied DNA Sciences Inc.

Receive notifications about Applied DNA Sciences Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.